Toxicology – Acetaminophen (Paracetamol): Acute Single Ingestion

Core Concept

Acetaminophen (paracetamol) is a widely used analgesic and antipyretic. Acute overdose can cause severe centrilobular hepatic necrosis and acute liver failure, even though patients may initially appear well.

The specific antidote is N-acetylcysteine (NAC).

The major principles are:

• Obtain an appropriately timed serum acetaminophen concentration.
• Use the Rumack–Matthew nomogram only when its assumptions are satisfied.
• Start NAC promptly when indicated.
• Do not delay NAC when waiting for testing would push treatment beyond the optimal early window.
• Continue or stop NAC according to clinical and laboratory endpoints rather than an inflexible historical course length.

Common Sources of Exposure

Acetaminophen is found in:

• Single-ingredient analgesics
• Cold and flu products
• Sleep preparations
• Prescription combination analgesics
• Pediatric liquids
• Extended-release preparations

Combination products may also contain:

• Opioids
• Antihistamines
• Decongestants
• Caffeine
• Other medications

Therefore, the exact product and all active ingredients should be identified whenever possible.

Mechanism of Toxicity

At therapeutic exposure, most acetaminophen undergoes hepatic:

• Glucuronidation
• Sulfation

These pathways generate relatively nontoxic metabolites.

A smaller fraction undergoes CYP-mediated oxidation, particularly involving CYP2E1, producing:

N-acetyl-p-benzoquinone imine (NAPQI)

NAPQI is a highly reactive toxic metabolite.

Role of Glutathione

Normally:

Acetaminophen → NAPQI → glutathione conjugation → nontoxic metabolites

After sufficiently large exposure:

• Normal conjugation pathways become overwhelmed.
• NAPQI production becomes clinically important.
• Hepatic glutathione becomes depleted.
• Unneutralized NAPQI binds cellular proteins.

This initiates:

• Oxidative stress
• Mitochondrial dysfunction
• Hepatocyte injury
• Centrilobular hepatic necrosis

Why NAC Works

NAC provides cysteine needed for glutathione synthesis and helps restore the liver’s ability to detoxify NAPQI.

Its benefits also extend beyond simple glutathione replacement, particularly in established liver injury, where antioxidant, mitochondrial, and microcirculatory effects may contribute.

Therefore:

NAC remains beneficial even when treatment begins after the ideal early period.

Risk Assessment

A reported dose is useful for deciding who requires evaluation, but serum acetaminophen concentration is more important for definitive risk assessment after a known-time acute ingestion.

Do not base treatment solely on the patient’s estimated number of tablets.

Histories may be inaccurate because of:

• Intentional under-reporting
• Uncertainty about tablet strength
• Combination products
• Incorrect timing
• Vomiting
• Delayed absorption

Clinical Course

Acetaminophen poisoning is classically described in stages, although individual patients do not always follow them precisely.

Early Phase – First 24 Hours

Patients may have:

• Nausea
• Vomiting
• Diaphoresis
• Pallor
• Malaise

But many patients are:

Completely asymptomatic.

This is one of the most important pitfalls in acetaminophen poisoning.

A well-appearing patient shortly after overdose can still develop severe hepatotoxicity.

Developing Hepatic Injury

Over approximately the next 1–3 days, patients may develop:

• Right upper quadrant discomfort
• Increasing AST and ALT
• Increasing INR
• Nausea and vomiting
• Hepatic tenderness

Laboratory abnormalities may become dramatic even while some initial GI symptoms improve.

Severe Toxicity

Severe poisoning can progress to acute liver failure with:

• Coagulopathy
• Hypoglycemia
• Lactic acidosis
• Encephalopathy
• Cerebral edema
• Hyperammonemia
• Acute kidney injury
• Multiorgan failure
• Death

Maximum hepatic injury often becomes evident several days after ingestion.

Recovery

Patients who survive the critical period may undergo substantial hepatic regeneration.

Recovery can be complete because the liver has considerable regenerative capacity.

Some patients with fulminant failure, however, require liver transplantation.

Serum Acetaminophen Concentration

For a single acute ingestion at a known time, obtain a serum acetaminophen concentration at:

4 hours after ingestion or as soon as possible thereafter.

A concentration obtained substantially before 4 hours cannot reliably exclude toxicity because absorption may still be occurring.

Rumack–Matthew Nomogram

The Rumack–Matthew nomogram relates:

Serum acetaminophen concentration ↔ time since ingestion

to estimate hepatotoxicity risk after a single acute ingestion.

In many current protocols, the treatment line begins at approximately 150 µg/mL at 4 hours and declines with time.

Country-specific protocols may differ, so the applicable local treatment line should be used.

When the Nomogram Is Valid

The nomogram is appropriate when:

• There was a single acute ingestion.
• The time of ingestion is reasonably reliable.
• The concentration was obtained within the validated post-ingestion interval.
• There is not already an alternative pattern such as repeated supratherapeutic ingestion.

When the Nomogram Is NOT Valid

Do not use it for:

• Unknown ingestion time
• Repeated supratherapeutic ingestion
• Staggered ingestion over a prolonged period
• Chronic excessive use
• Patients already presenting with established acetaminophen-associated liver injury

These situations require a different assessment using acetaminophen concentration, hepatic tests, history, and clinical findings.

Extended-Release Acetaminophen

Extended-release preparations can produce delayed or prolonged absorption.

A single early concentration below the treatment line may therefore be insufficient in selected cases.

Serial concentrations may be needed, especially when:

• Extended-release acetaminophen was taken
• The initial concentration is detectable but below the treatment line
• Absorption appears delayed

Current poison-center or toxicology guidance should determine the repeat-testing strategy.

Coingestants and Delayed Absorption

Delayed acetaminophen absorption can also occur when coingestants slow gastric emptying, particularly:

• Opioids
• Antimuscarinic drugs

Large tablet burdens or pharmacobezoar formation can also produce unusual kinetics.

A concentration that rises unexpectedly should prompt reassessment rather than blind reliance on the first value.

When to Start NAC Before the Level Returns

NAC is most effective when started early.

If a potentially toxic acute ingestion occurred and the acetaminophen result will not be available before approximately 8 hours after ingestion, NAC should generally be started empirically while awaiting the result.

Treatment can later be reassessed once reliable laboratory information is available.

Why the First 8 Hours Matter

When NAC is initiated within roughly the first 8 hours after an acute overdose, protection against serious hepatotoxicity is excellent.

However:

8 hours is not a cutoff after which NAC becomes useless.

Late treatment can still improve outcomes and should not be withheld when toxicity is suspected or established.

Unknown Time of Ingestion

If the ingestion time cannot be established, the Rumack–Matthew nomogram cannot be interpreted reliably.

Evaluation generally includes:

• Serum acetaminophen concentration
• AST
• ALT
• INR
• Renal function
• Clinical assessment

A measurable acetaminophen concentration in an appropriate overdose context or evidence of hepatic injury may justify NAC.

Late Presentation

Patients presenting after the standard nomogram window require assessment for established injury rather than simple plotting.

Important tests include:

• Acetaminophen concentration
• AST/ALT
• INR
• Creatinine
• Glucose
• Electrolytes
• Acid–base status in severe illness

NAC should be given when acetaminophen-associated hepatic injury is suspected, even if the serum acetaminophen concentration has already fallen substantially or become undetectable.

An Undetectable Level Does Not Always Exclude Acetaminophen Toxicity

This is especially important in delayed presentation.

By the time acute liver failure develops, the parent acetaminophen may already have been cleared.

Therefore:

Undetectable acetaminophen + marked compatible hepatotoxicity ≠ exclusion of acetaminophen poisoning.

History and biochemical pattern remain important.

Liver Tests

Monitor:

• AST
• ALT
• INR
• Bilirubin

AST and ALT may become extremely elevated in severe acetaminophen hepatotoxicity.

However, the older statement that PT prolongation is always the earliest manifestation should not be treated as a universal rule.

The pattern and trajectory of multiple markers are more informative.

Renal Injury

Acute kidney injury can accompany severe acetaminophen poisoning.

Mechanisms may include:

• Direct nephrotoxicity
• Acute tubular injury
• Hypoperfusion
• Multiorgan failure

Importantly, renal injury can occasionally occur even without dramatic hepatic failure.

Monitor:

• Creatinine
• Urine output
• Electrolytes

Metabolic Acidosis

A massive acute ingestion can occasionally produce early high-anion-gap metabolic acidosis and elevated lactate, sometimes before classic hepatic failure develops.

Later acidosis may result from:

• Liver failure
• Shock
• Renal failure
• Impaired lactate clearance

Other causes of metabolic acidosis must still be investigated.

Massive Acetaminophen Poisoning

Exceptionally large acute exposures can present differently from typical poisoning.

Possible early manifestations include:

• Altered mental status
• Severe metabolic acidosis
• Markedly elevated lactate
• Hemodynamic instability

These cases warrant immediate medical-toxicology/poison-center consultation.

Selected extraordinarily severe cases may require hemodialysis in addition to NAC, particularly when early mitochondrial toxicity is profound.

Hemodialysis

Most acetaminophen poisonings do not require dialysis.

Dialysis is reserved for exceptional severe poisoning.

Because NAC can also be removed during dialysis, antidotal therapy requires specialist-directed adjustment when extracorporeal treatment is used.

Activated Charcoal

Activated charcoal may be considered after a substantial recent ingestion when:

• The toxin is still likely to be in the gastrointestinal tract.
• The patient can safely receive charcoal.
• The airway is adequately protected.

Its usefulness may extend beyond a rigid 1-hour cutoff in selected large, extended-release, or delayed-absorption ingestions.

Charcoal and NAC

Activated charcoal can adsorb orally administered NAC to some degree, but this interaction does not justify withholding indicated GI decontamination or antidotal therapy.

Current treatment strategy should account for:

• NAC route
• Timing
• Clinical circumstances

Ipecac – Obsolete

The source recommends inducing vomiting with ipecac.

This is no longer recommended.

Ipecac:

• Does not improve clinical outcomes
• Can delay antidotal therapy
• Causes persistent vomiting
• Increases aspiration concerns

It has no routine role in modern acetaminophen overdose management.

Gastric Lavage

Routine gastric lavage is also obsolete.

It is not standard treatment for acetaminophen poisoning and is reserved, if ever considered, for extraordinary circumstances after specialist consultation.

Activated charcoal is the preferred gastrointestinal decontamination method when decontamination is appropriate.

N-Acetylcysteine

NAC is highly effective and should be used when:

• The appropriately timed acetaminophen concentration reaches or exceeds the applicable treatment line.
• A potentially toxic ingestion occurred and laboratory results will be significantly delayed.
• The time of ingestion is unknown and findings suggest clinically important exposure.
• Acetaminophen-associated hepatic injury is present or strongly suspected.
• Other high-risk circumstances warrant treatment based on toxicology guidance.

Oral vs Intravenous NAC

Both routes can be effective.

IV NAC

Often preferred when there is:

• Persistent vomiting
• Altered mental status
• Acute liver failure
• Inability to tolerate oral treatment
• Need for controlled hospital administration

Oral NAC

Can also be effective when appropriately administered and tolerated.

Modern practice commonly uses IV NAC in hospital settings.

Important Correction – Never Inject the Oral Formulation

The historical source discusses administering oral NAC formulation intravenously.

That is not appropriate modern practice.

Only a formulation specifically manufactured and approved for intravenous administration should be given IV.

Improvised IV administration of an oral formulation should not be performed.

Duration of NAC Therapy

Historical protocols used fixed treatment durations.

Modern practice increasingly emphasizes clinical stopping criteria.

NAC should generally continue if there is:

• Detectable clinically relevant acetaminophen
• Rising or persistently abnormal aminotransferases
• Worsening hepatic function
• Significant coagulopathy attributable to hepatic injury
• Other evidence of ongoing toxicity

Treatment can be stopped when appropriate biochemical and clinical recovery criteria are satisfied.

Do Not Stop NAC Solely Because the Clock Ran Out

A patient with ongoing hepatic injury should not have NAC discontinued merely because a standard protocol duration has been completed.

Conversely, some patients may satisfy validated stopping criteria without needing unnecessarily prolonged treatment.

IV NAC Reactions

IV NAC can cause non-IgE-mediated anaphylactoid reactions.

Possible findings include:

• Flushing
• Pruritus
• Urticaria
• Angioedema
• Bronchospasm
• Hypotension

These reactions are often manageable.

Previous NAC Reaction Is Not Usually an Absolute Contraindication

The older statement that previous anaphylaxis to NAC automatically precludes future use is too restrictive.

When NAC is lifesaving, prior reaction requires:

• Careful risk assessment
• Appropriate monitoring
• Modification of administration when appropriate
• Treatment of recurrent hypersensitivity if it occurs

A prior reaction does not automatically eliminate NAC as an option.

Pregnancy

The historical FDA pregnancy letter category is obsolete.

Pregnant patients should generally receive NAC using the same toxicologic indications as nonpregnant patients.

Maternal stabilization and prevention of maternal liver failure are central to fetal protection.

NAC crosses the placenta.

Neonate After Maternal Overdose

The source recommends automatically giving every infant born to a mother with acetaminophen toxicity a fixed NAC course.

This is not a universal modern rule.

Neonatal evaluation and treatment depend on:

• Timing and severity of maternal poisoning
• Maternal treatment
• Timing of delivery
• Neonatal acetaminophen exposure
• Neonatal hepatic findings
• Specialist assessment

Delivery should not be induced solely as a method of treating maternal acetaminophen poisoning.

Alcohol Use – Important Nuance

Chronic alcohol use can contribute to:

• Malnutrition
• Reduced glutathione reserves
• Altered CYP2E1 activity

However, alcohol history alone does not replace standard risk assessment.

Acute ethanol co-ingestion can transiently compete for CYP2E1, while chronic alcohol-associated nutritional deficiency may increase vulnerability in certain circumstances.

Do not withhold or alter indicated NAC simply because alcohol was involved.

Malnutrition

Malnutrition and prolonged fasting may reduce hepatic glutathione availability.

These factors become particularly relevant in:

• Repeated supratherapeutic ingestion
• Delayed presentation
• Patients with established liver injury

They do not eliminate the need for standard concentration-based assessment after a straightforward known-time single acute ingestion.

Enzyme-Inducing Drugs

Older sources sometimes strongly emphasized CYP-inducing medications as automatically increasing acute acetaminophen toxicity.

The clinical importance is more nuanced than previously suggested.

Medication history remains relevant, but standard acute risk assessment should not be replaced by assumptions based solely on enzyme induction.

Acute Liver Failure

Severe acetaminophen toxicity can cause:

• Encephalopathy
• Coagulopathy
• Hypoglycemia
• Lactic acidosis
• Hyperammonemia
• Cerebral edema
• Renal failure
• Multiorgan dysfunction

These patients require intensive care and early involvement of a liver transplant center.

Transplant Assessment

The source lists older fixed prognostic criteria.

Modern transplant decisions use the complete clinical picture and may incorporate established systems such as King’s College criteria, along with:

• Lactate
• Arterial pH
• INR
• Creatinine
• Encephalopathy
• Hemodynamic status
• Clinical trajectory

No single laboratory value should be used in isolation.

Early referral is preferable to waiting for irreversible deterioration.

Coagulopathy and Blood Products

An elevated INR in acetaminophen-associated liver failure is an important marker of hepatic dysfunction.

Routine correction of an abnormal INR with plasma solely to normalize the laboratory value is generally avoided when there is no clinically important bleeding.

Unnecessary plasma can:

• Cause volume overload
• Produce transfusion reactions
• Obscure INR trends used to assess hepatic function

Blood products are reserved for appropriate clinical indications such as significant bleeding or selected invasive procedures.

Vitamin K

Vitamin K does not correct the fundamental loss of hepatic synthetic function in severe acetaminophen-induced liver failure.

It may be appropriate if concomitant vitamin K deficiency is suspected, but it is not an antidote for acetaminophen hepatotoxicity.

Monitoring During NAC

Important serial assessments include:

• Acetaminophen concentration when relevant
• AST and ALT
• INR
• Creatinine
• Electrolytes
• Glucose

In severe toxicity also consider:

• Blood gas
• Lactate
• Phosphate
• Mental status
• Ammonia in appropriate acute liver failure assessment

Serial Acetaminophen Levels – Modern Correction

The older statement that repeated acetaminophen levels are essentially never useful after NAC starts is too broad.

Repeat concentrations can be important when:

• Extended-release preparations were ingested
• Delayed absorption is suspected
• A large ingestion occurred
• Concentrations remain detectable
• Treatment stopping criteria are being assessed
• The concentration unexpectedly rises
• Dialysis is being considered or performed

Differential Diagnosis of Severe Hepatic Injury

Other causes include:

• Viral hepatitis
• Ischemic hepatitis
• Autoimmune hepatitis
• Amanita mushroom poisoning
• Valproate toxicity
• Certain herbal or plant toxins
• Other drug-induced liver injury

However, acetaminophen should remain high in the differential for otherwise unexplained acute liver failure.

Psychiatric and Safety Assessment

When overdose was intentional, medical stabilization should be followed by an appropriate mental-health and safety evaluation.

This assessment should not delay emergency toxicologic treatment.

Discharge Principles

A patient with a straightforward known-time acute ingestion may be medically cleared when:

• Appropriate acetaminophen testing excludes a toxic exposure, or indicated treatment has been completed
• There is no evidence of evolving hepatic or renal injury
• Clinical status is stable
• Delayed absorption is not a concern
• Coingestants have been appropriately addressed
• Appropriate safety assessment has been completed when the ingestion was intentional

Patients with hepatic injury require continued monitoring until recovery is clearly established.

Prevention

Unintentional overdose frequently occurs because patients unknowingly take multiple acetaminophen-containing products simultaneously.

Education should emphasize:

• Check active ingredients.
• Avoid duplicating acetaminophen-containing medications.
• Use age-appropriate pediatric formulations.
• Measure pediatric liquid medications accurately.
• Follow current product-specific maximum daily dosing instructions.

Important Modernization of the Older Source

• Acetaminophen toxicity results primarily from excessive formation of NAPQI, glutathione depletion, mitochondrial injury, and hepatocellular necrosis.
• A patient can appear completely well during the early phase of a potentially fatal overdose.
• For a known-time single acute ingestion, obtain the acetaminophen concentration at 4 hours or later and apply the appropriate Rumack–Matthew treatment line.
• A level obtained too early cannot reliably exclude toxicity.
• The Rumack–Matthew nomogram does not apply to unknown-time, repeated, staggered, or chronic excessive ingestion.
• Extended-release preparations and drugs that delay gastric emptying may require repeat concentrations.
• Start NAC empirically if waiting for the concentration would significantly delay treatment beyond the optimal early window.
• NAC remains beneficial after 8 hours and even after hepatic injury has developed.
• An undetectable acetaminophen concentration in a late presenter does not exclude acetaminophen-induced liver failure.
• Modern NAC treatment should incorporate clinical stopping criteria, rather than blindly stopping after a fixed duration.
• Repeat acetaminophen concentrations remain useful in selected patients despite the older source’s contrary statement.
• Activated charcoal may be useful after selected recent substantial ingestions.
• Ipecac is obsolete, and routine gastric lavage is not recommended.
• Never administer an oral NAC preparation intravenously.
• Previous NAC hypersensitivity is not automatically an absolute contraindication when antidotal therapy is required.
• Massive acetaminophen poisoning can cause early lactic acidosis, altered consciousness, and mitochondrial dysfunction; dialysis is considered only in exceptional severe cases.
• 4F-PCC/FFP or vitamin K should not routinely be used merely to normalize INR in acetaminophen-associated liver failure.
• Severe acute liver failure warrants early transplant-center involvement.
• Pregnancy is not a reason to withhold NAC.
• Historical FDA pregnancy categories are obsolete.
• Exact NAC dosing should follow current product, poison-center, or medical-toxicology protocols.

Key Points

• Acetaminophen → CYP metabolism → NAPQI → glutathione depletion → hepatic injury.
• NAC replenishes glutathione-related defenses and remains the specific antidote.
• Early absence of symptoms does not exclude severe poisoning.
• Known-time single acute ingestion → ≥4-hour acetaminophen concentration → Rumack–Matthew nomogram.
• Do not use the nomogram for unknown-time, repeated, staggered, or chronic exposures.
• When waiting for testing would substantially delay therapy, start NAC first and reassess later.
• NAC is most protective when given early but can remain lifesaving in late toxicity.
• Extended-release products or delayed gastric emptying can produce delayed concentration peaks.
• Massive poisoning may cause early metabolic acidosis and altered mental status before classic hepatic failure.
• Continue NAC when acetaminophen remains clinically relevant or hepatic injury is still evolving.
• Ipecac and routine gastric lavage have no role in modern routine management.
• Acute liver failure requires intensive monitoring and early transplant-center consultation.